Title:
C-2 MODIFIED ERYTHROMYCIN DERIVATIVES
Document Type and Number:
WIPO Patent Application WO2000069875
Kind Code:
A9
Abstract:
A compound having the formula selected from the group consisting of a compound of formula (I), a compound of formula (II), and a compound of formula (III) as well as pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. Also provided are pharmaceutically acceptable compositions, methods of treating bacterial infections, and processes for the preparation of the compounds.
Inventors:
MA ZHENKUN
OR YAT SUN
PHAN LY TAM
SUOMING ZHANG
CLARK RICHARD F
OR YAT SUN
PHAN LY TAM
SUOMING ZHANG
CLARK RICHARD F
Application Number:
PCT/US2000/012202
Publication Date:
February 21, 2002
Filing Date:
May 04, 2000
Export Citation:
Assignee:
ABBOTT LAB (US)
International Classes:
A61K31/7048; A61P31/04; C07H17/08; (IPC1-7): C07H17/08; A61K31/70
Download PDF:
Previous Patent: NOVEL CRYSTALLINE FORMS OF A MACROLIDE ANTIBIOTIC
Next Patent: 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES
Next Patent: 4'-C-ETHYNYL PYRIMIDINE NUCLEOSIDES